This acceptance marks the fifth major medical conference this year to feature bexmarilimab in an oral session, reinforcing the drug's unique mechanism in hematologic malignancies and potential to ...

In less than 2.5 years, the Unified Patent Court (UPC) has established itself as a hallmark for high-profile patent ...

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the ...

Developed by Ascentage Pharma, lisaftoclax is an orally available Bcl-2 inhibitor. Early data from the studies have demonstrated effects on hematologic malignancies and solid tumors. Lisaftoclax is ...

HTC-19 in Leuven will showcase the latest advancements in hyphenated techniques. This preview offers a glimpse of what you ...

The 54th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 2025), was held from June 15–19, 2025, in Bruges, Belgium. This “Column Watch” installment ...

International Seaways, Inc. (NYSE: INSW) (the "Company," "Seaways," or "INSW"), one of the largest tanker companies worldwide ...

Q3 2025 Earnings Call Transcript November 4, 2025 Rhythm Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Q3 2025 Earnings Call November 12, 2025 8:00 AM ESTCompany ParticipantsJessie Yeung - Vice President of Finance, ...

Albany International Corp. (NYSE:AIN) today reported operating results for its third quarter of 2025, which ended September 30, 2025.

ARS Pharmaceuticals, Inc. ( SPRY) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Good morning and welcome to ARS Pharmaceuticals Conference Call. [Operator Instructions] Please be advised that ...

RLX Technology Inc. misses on earnings expectations. Reported EPS is $0.02 EPS, expectations were $0.03265.